The Glia-Derived Alarmin IL-33 Orchestrates the Immune Response and Promotes Recovery following CNS Injury

Neuron

Volumn 85, Issue 4, 2015, Pages 703-709

  Gadani, Sachin P ^a   Walsh, James T ^a   Smirnov, Igor ^a   Zheng, Jingjing ^a,b   Kipnis, Jonathan ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; IL1RL1 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-33, MOUSE; KI 67 ANTIGEN; NERVE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BONE MARROW CELL; CELL INFILTRATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; GENE INDUCTION; GLIA; INNATE IMMUNITY; MICROGLIA; MITOSIS; MONOCYTE; MOUSE; NERVOUS SYSTEM INJURY; NEUROPHYSIOLOGICAL RECRUITMENT; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WHITE MATTER; ANIMAL; C57BL MOUSE; CELL CULTURE; CENTRAL NERVOUS SYSTEM DISEASES; CONVALESCENCE; DEFICIENCY; DISEASE MODEL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IN VITRO STUDY; MALE; METABOLISM; NERVE CELL; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA GANGLION CELL; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; IN VITRO TECHNIQUES; INTERLEUKINS; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; RECEPTORS, CHEMOKINE; RECEPTORS, INTERLEUKIN; RECOVERY OF FUNCTION; RETINAL GANGLION CELLS;

EID: 84924988052     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2015.01.013     Document Type: Article

References (31)

1. Alves-Filho J.C., SÔnego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., Basile-Filho A., McKenzie A.N., Xu D., Cunha F.Q., Liew F.Y. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat. Med. 2010, 16:708-712.
2. Basso D.M., Fisher L.C., Anderson A.J., Jakeman L.B., McTigue D.M., Popovich P.G. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J.Neurotrauma 2006, 23:635-659.
3. Cahoy J.D., Emery B., Kaushal A., Foo L.C., Zamanian J.L., Christopherson K.S., Xing Y., Lubischer J.L., Krieg P.A., Krupenko S.A., et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J.Neurosci. 2008, 28:264-278.
4. Chapuis J., Hot D., Hansmannel F., Kerdraon O., Ferreira S., Hubans C., Maurage C.A., Huot L., Bensemain F., Laumet G., et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol. Psychiatry 2009, 14:1004-1016.
5. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 1994, 6:712-724.
6. Evans T.A., Barkauskas D.S., Myers J.T., Hare E.G., You J.Q., Ransohoff R.M., Huang A.Y., Silver J. High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury. Exp. Neurol. 2014, 254:109-120.
7. Grossman S.D., Rosenberg L.J., Wrathall J.R. Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp. Neurol. 2001, 168:273-282.
8. Hsieh C.L., Kim C.C., Ryba B.E., Niemi E.C., Bando J.K., Locksley R.M., Liu J., Nakamura M.C., Seaman W.E. Traumatic brain injury induces macrophage subsets in the brain. Eur. J. Immunol. 2013, 43:2010-2022.
9. Jiang H.R., Milovanović M., Allan D., Niedbala W., Besnard A.G., Fukada S.Y., Alves-Filho J.C., Togbe D., Goodyear C.S., Linington C., et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur. J. Immunol. 2012, 42:1804-1814.
10. Kempuraj D., Khan M.M., Thangavel R., Xiong Z., Yang E., Zaheer A. Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J.Neuroimmune Pharmacol. 2013, 8:643-650.
11. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J.Neurosci. 2009, 29:13435-13444.
12. Kipnis J., Avidan H., Caspi R.R., Schwartz M. Dual effect of CD4+CD25+ regulatory Tcells in neurodegeneration: a dialogue with microglia. Proc. Natl. Acad. Sci. USA 2004, 101(2):14663-14669.
13. Kroner A., Greenhalgh A.D., Zarruk J.G., Passos Dos Santos R., Gaestel M., David S. TNF and increased intracellular iron alter macrophage polarization to a detrimental M1 phenotype in the injured spinal cord. Neuron 2014, 83:1098-1116.
14. Kurowska-Stolarska M., Stolarski B., Kewin P., Murphy G., Corrigan C.J., Ying S., Pitman N., Mirchandani A., Rana B., van Rooijen N., et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J.Immunol. 2009, 183:6469-6477.
15. Levkovitch-Verbin H., Harris-Cerruti C., Groner Y., Wheeler L.A., Schwartz M., Yoles E. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest. Ophthalmol. Vis. Sci. 2000, 41:4169-4174.
16. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10:103-110.
17. Liu X.Z., Xu X.M., Hu R., Du C., Zhang S.X., McDonald J.W., Dong H.X., Wu Y.J., Fan G.S., Jacquin M.F., et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J.Neurosci. 1997, 17:5395-5406.
18. Lüthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., Brumatti G., Taylor R.C., Kersse K., Vandenabeele P., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
19. Lytle J.M., Wrathall J.R. Glial cell loss, proliferation and replacement in the contused murine spinal cord. Eur. J. Neurosci. 2007, 25:1711-1724.
20. Ma M., Wei T., Boring L., Charo I.F., Ransohoff R.M., Jakeman L.B. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion. J.Neurosci. Res. 2002, 68:691-702.
21. Oboki K., Ohno T., Kajiwara N., Arae K., Morita H., Ishii A., Nambu A., Abe T., Kiyonari H., Matsumoto K., et al. IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc. Natl. Acad. Sci. USA 2010, 107:18581-18586.
22. Ortín-Martínez A., Nadal-Nicolás F.M., Jiménez-López M., Alburquerque-Béjar J.J., Nieto-López L., García-Ayuso D., Villegas-Pérez M.P., Vidal-Sanz M., Agudo-Barriuso M. Number and distribution of mouse retinal cone photoreceptors: differences between an albino (Swiss) and a pigmented (C57/BL6) strain. PLoS ONE 2014, 9:e102392.
23. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
24. Schori H., Yoles E., Wheeler L.A., Raveh T., Kimchi A., Schwartz M. Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity. Eur. J. Neurosci. 2002, 16:557-564.
25. Shechter R., London A., Varol C., Raposo C., Cusimano M., Yovel G., Rolls A., Mack M., Pluchino S., Martino G., et al. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med. 2009, 6:e1000113.
26. Shechter R., Miller O., Yovel G., Rosenzweig N., London A., Ruckh J., Kim K.W., Klein E., Kalchenko V., Bendel P., et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
27. Trivedi A., Olivas A.D., Noble-Haeusslein L.J. Inflammation and Spinal Cord Injury: Infiltrating Leukocytes as Determinants of Injury and Repair Processes. Clin. Neurosci. Res. 2006, 6:283-292.
28. Walsh J.T., Watson N., Kipnis J. T cells in the central nervous system: messengers of destruction or purveyors of protection?. Immunology 2014, 141:340-344.
29. Walsh J.T., Hendrich S., Boato F., Smirnov I., Zheng J., Lukens J.R., Gadani S., Hechler D., Golz G., Rosenberg K., et al. MHCII-independent CD4+ Tcells protect injured CNS neurons via IL-4. J.Clin. Invest. 2015, Published January 20, 2015. 10.1172/JCI76210.
30. Yasuoka S., Kawanokuchi J., Parajuli B., Jin S., Doi Y., Noda M., Sonobe Y., Takeuchi H., Mizuno T., Suzumura A. Production and functions of IL-33 in the central nervous system. Brain Res. 2011, 1385:8-17.
31. Yoles E., Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol. 1998, 153:1-7.